Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Medicure (MCUJF) Net Equity Issued and Repurchased (2016 - 2025)

Historic Net Equity Issued and Repurchased for Medicure (MCUJF) over the last 14 years, with Q3 2025 value amounting to -$451128.5.

  • Medicure's Net Equity Issued and Repurchased rose 3549.16% to -$451128.5 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year decrease of 4485.45%. This contributed to the annual value of $2.9 million for FY2021, which is 4066.89% up from last year.
  • Medicure's Net Equity Issued and Repurchased amounted to -$451128.5 in Q3 2025, which was up 3549.16% from -$1.8 million recorded in Q2 2025.
  • Medicure's 5-year Net Equity Issued and Repurchased high stood at $5.0 million for Q1 2025, and its period low was -$1.8 million during Q2 2025.
  • Its 5-year average for Net Equity Issued and Repurchased is $1.4 million, with a median of $527656.7 in 2023.
  • Per our database at Business Quant, Medicure's Net Equity Issued and Repurchased surged by 127618.19% in 2022 and then plummeted by 99154.43% in 2025.
  • Quarter analysis of 5 years shows Medicure's Net Equity Issued and Repurchased stood at $310194.4 in 2021, then skyrocketed by 1020.97% to $3.5 million in 2022, then tumbled by 95.77% to $146948.3 in 2023, then crashed by 575.9% to -$699333.0 in 2024, then soared by 35.49% to -$451128.5 in 2025.
  • Its Net Equity Issued and Repurchased stands at -$451128.5 for Q3 2025, versus -$1.8 million for Q2 2025 and $5.0 million for Q1 2025.